Abstract:Osteoporosis is a major concern worldwide and can be attributed to an imbalance between osteoblastic bone formation and osteoclastic bone resorption due to the natural aging process. Heritable factors account for 60–80% of optimal bone mineralization; however, the finer details of pathogenesis remain to be elucidated. Micro RNA (miRNA) and long-non-coding RNA (lncRNA) are two targets that have recently come into the spotlight due to their ability to control gene expression at the post-transcriptional level and provide epigenetic modification. miRNAs are a class of non-coding RNAs that are approximately 18–25 nucleotides long. It is thought that up to 60% of human protein-coding genes may be regulated by miRNAs. They have been found to regulate gene expression that controls osteoblast-dependent bone formation and osteoclast-related bone remodeling. lncRNAs are highly structured RNA transcripts longer than 200 nucleotides that do not translate into proteins. They have very complex secondary and tertiary structures and the same degradation processes as messenger RNAs. The fact that they have a rapid turnover is due to their sponge function in binding the miRNAs that lead to a degradation of the lncRNA itself. They can act as signaling, decoy, and framework molecules, or as primers. Current evidence suggests that lncRNAs can act as chromatin and transcriptional as well as post-transcriptional regulators. With regards to osteoporosis, lncRNA is thought to be involved in the proliferation, apoptosis, and inflammatory response of the bone. This review, which is based on a systematic appraisal of the current literature, provides current molecular and genetic opinions on the roles of miRNAs and lncRNAs in osteoporosis. Further research into the epigenetic modification and the regulatory roles of these molecules will bring us closer to potential disease-modifying treatment for osteoporosis. However, more issues regarding the detailed actions of miRNAs and lncRNAs in osteoporosis remain unknown and controversial and warrant future investigation.

Micrornas In Osteoclastogenesis And Function: Potential Therapeutic Targets For Osteoporosis

Research and Application of Target Therapy for Osteoporosis

MicroRNAs as Potential Targets for Treatment of Osteoclast-Related Diseases

Therapeutic Potential of Micrornas in Osteoporosis Function by Regulating the Biology of Cells Related to Bone Homeostasis

The Role of Micrornas in Osteoclasts and Osteoporosis.

Regulation of osteoclast differentiation by microRNAs

MicroRNAs in bone development and their diagnostic and therapeutic potentials in osteoporosis

Current Progress On Microrna-Based Gene Delivery In The Treatment Of Osteoporosis And Osteoporotic Fracture

MicroRNAs regulate bone metabolism

The Emerging Role of Micrornas in Bone Remodeling and Its Therapeutic Implications for Osteoporosis

MicroRNAs and Their Roles in Osteoclast Differentiation

Targeting Mirnas in Osteoblast Differentiation and Bone Formation

The expression and function of microRNAs in bone homeostasis.

The Role of Micro RNA and Long-Non-Coding RNA in Osteoporosis

The research progress in the role of microRNAs in the pathogenesis of osteoporosis

The Regulatory Roles of MicroRNAs in Bone Remodeling and Perspectives as Biomarkers in Osteoporosis.

MicroRNA Alterations for Diagnosis, Prognosis, and Treatment of Osteoporosis: A Comprehensive Review and Computational Functional Survey

MicroRNA Alterations for Diagnosis, Prognosis, and Treatment of Osteoporosis: A Comprehensive Review and Computational Functional Survey.

miRNA regulating the differentiation and function of osteoblasts and osteoclasts

The Role of Micrornas in Bone Remodeling.

Validation of Downregulated Micrornas During Osteoclast Formation and Osteoporosis Progression.